Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel

Author： Braak B.   Siezen C.   Kannegieter N.   Koedoot E.   Water B.   Laan J.  

Publisher： Springer Publishing Company

ISSN： 0340-5761

Source： Archives of Toxicology, Vol.88, Iss.4, 2014-04, pp. : 953-966

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Transport Mechanism-Based Drug Molecular Design: Novel Camptothecin Analogues to Circumvent ABCG2-associated Drug Resistance of Human Tumor Cells

By  

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 313-325

Bentham Science Publishers

Access to resources Recommend Favorite

Mitogenic Signal Transduction in Human Breast Cancer Cells

By Strobl J.S.   Wonderlin W.F.   Flynn D.C.  

General Pharmacology, Vol. 26, Iss. 8, 1995-12 ,pp. : 1643-1649

Elsevier

Access to resources Recommend Favorite

The NK-1 Receptor is Involved in the Antitumoural Action of L-733,060 and in the Mitogenic Action of Substance P on Human Pancreatic Cancer Cell Lines

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 5, 2006-07 ,pp. : 323-329

Bentham Science Publishers

Access to resources Recommend Favorite

Evidence for receptor subtype cross-talk in the mitogenic action of serotonin on human small-cell lung carcinoma cells

By Vicentini L.M.   Cattaneo M.G.   Fesce R.  

European Journal of Pharmacology, Vol. 318, Iss. 2, 1996-12 ,pp. : 497-504

Elsevier

Access to resources Recommend Favorite

Mechanism-based Combinations with Pim Kinase Inhibitors in Cancer Treatments

By  

Current Pharmaceutical Design, Vol. 20, Iss. 42, 2014-12 ,pp. : 6670-6681

Bentham Science Publishers

Access to resources Recommend Favorite